mci 9038 has been researched along with Cerebral Arteriosclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Geng, N; Li, J; Li, ZG; Liu, LY; Sun, ZR; Wang, PF; Yu, JC; Yuan, HC; Zhao, GC; Zhu, LN | 1 |
Fushimi, K; Horiguchi, H; Matsubara, T; Nakajima, S; Wada, T; Yahagi, N; Yasunaga, H | 1 |
Koizumi, T; Morii, F; Nagakane, Y; Ohara, T; Tanaka, E; Yamamoto, Y | 1 |
1 review(s) available for mci 9038 and Cerebral Arteriosclerosis
Article | Year |
---|---|
[Concept of branch atheromatous disease (BAD) and its clinical significance].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Drug Therapy, Combination; Edaravone; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles | 2010 |
2 other study(ies) available for mci 9038 and Cerebral Arteriosclerosis
Article | Year |
---|---|
Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis.
Topics: Arginine; Drug Therapy, Combination; Humans; Intracranial Arteriosclerosis; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke, Lacunar; Sulfonamides; Treatment Outcome | 2021 |
Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arginine; Case-Control Studies; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Arteriosclerosis; Intracranial Thrombosis; Japan; Male; Middle Aged; Odds Ratio; Pipecolic Acids; Practice Guidelines as Topic; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome | 2016 |